Federal appeals court refuses to pause marijuana rescheduling

The D.C. Circuit denied an emergency stay sought by a drug-testing association and pharmaceutical interests, allowing the federal rescheduling process to continue while three consolidated challenges proceed. Oklahoma operators still face unresolved federal litigation, but the ruling removes an immediate obstacle to Schedule III and its potential 280E tax impact.